Ehrenkranz PD, Baptiste SL, Bygrave H, Ellman T, Doi N, et al.
2019-05-29 • PLOS Medicine
2019-05-29 • PLOS Medicine
In a Policy Forum, Peter Ehrenkranz and colleagues discuss the contribution of CD4 and viral load testing to outcomes for people with HIV in low- and middle-income countries.
Lee L, Mbingwani I, Kalua T, Spiers S, Duranti S, et al.
2019-05-09 • MSF Scientific Days International 2019
2019-05-09 • MSF Scientific Days International 2019
INTRODUCTION Resistance to antiretrovirals (ARV), particularly protease inhibitors (PI), threatens to roll back progress towards expanding access to effective antiretroviral therapy ...
Schramm B, Temfack E, Descamps D, Nicholas S, Peytavin G, et al.
2022-08-01 • Lancet HIV
2022-08-01 • Lancet HIV
BACKGROUND Many countries are now replacing non-nucleoside reverse transcriptase inhibitor (NNRTI)-based first-line antiretroviral therapy (ART) with a regimen containing tenofovir d...
